We sought to explore whether there was an impact on OS based on the presence of PM and the status of KRAS, BRAF, NRAS, any of RAS/BRAF, or three known driver mutations in colorectal cancer: TP53, APC, and PIK3CA (Supplementary Table S5). This evidence concerns the gene NRAS and colorectal cancer.